Abstract:CONTEXT: A symbiotic relationship between the liver and intestinal tract enables the healthy status of both organs. Microflora resident in intestinal lumen plays a significant role in hepatocytes function. Alterations to the type and amount of microorganisms that live in the intestinal tract can result in serious and harmful liver dysfunctions such as cirrhosis, nonalcoholic fatty liver disease, alcoholic liver disease, and hepatic encephalopathy. An increased number of pathogens, especially enterobacteriaceae, enterococci, and streptococci species causes the elevation of intestinal permeability and bacterial translocation. The presence of high levels of lipopolysaccharide (LPS) and bacterial substances in the blood result in a portal hypertension and ensuing hepatocytes damage. Several methods including the usage of antibiotics, prebiotics, and probiotics can be used to prevent the overgrowth of pathogens. Compared to prebiotic and antibiotic therapy, probiotics strains are a safer and less expensive therapy. Probiotics are "live microorganisms (according to the FAO/WHO) which when administered in adequate amounts confer a health benefit on the host".EVIDENCE ACQUISITIONS: Data from numerous preclinical and clinical trials allows for control of the flora bacteria quantity, decreases in compounds derived from bacteria, and lowers proinflammatory production such as TNF-α, IL-6 and IFN-γ via down-regulation of the nuclear factor kappa B (NF-κ B).RESULTS: On the other hand, probiotic can reduce the urease activity of bacterial microflora. Furthermore, probiotic decreases fecal pH value and reduces ammonia adsorption. In addition, the serum level of liver enzymes and other substances synthesized by the liver are modulated subsequent to probiotic consumption.CONCLUSIONS: According to our knowledge, Probiotic therapy as a safe, inexpensive and a noninvasive strategy can reduce pathophysiological symptoms and improve different types of liver diseases without side effects.

Role of Probiotics and Gut microbiota in Liver Diseases

Bile Acids and Microbiota: Multifaceted and Versatile Regulators of the Liver–Gut Axis

The Gut Microbiota: How Does It Influence the Development and Progression of Liver Diseases

Microbiota and Gut–Liver Axis: An Unbreakable Bond?

Infectious Microecology in Liver Disease

The Role of Gut Microbiota in Some Liver Diseases: From an Immunological Perspective

The role of the microbiome in liver disease

Role of Intestinal Microbes in Chronic Liver Diseases

Therapeutic Role of Probiotics Against Environmental-Induced Hepatotoxicity: Mechanisms, Clinical Perspectives, Limitations, and Future

Role of bile acids in liver diseases mediated by the gut microbiome

The gut–liver axis and gut microbiota in health and liver disease

Vital Members in the Gut Microbiotas Altered by Two Probiotic Bifidobacterium Strains Against Liver Damage in Rats

Probiotic as a Novel Treatment Strategy Against Liver Disease

The gut mycobiome: a novel player in chronic liver diseases

The Impact of Probiotic Bifidobacterium on Liver Diseases and the Microbiota

Effects of alterations in the intestinal microbial flora on liver diseases

[The gut-liver axis: how the gut promotes liver disease]

Importance of the gut microbiota in the gut-liver axis in normal and liver disease

Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions

Gut Microbiota Targeted Approach in the Management of Chronic Liver Diseases

Novel approaches to intervene gut microbiota in the treatment of chronic liver diseases